Literature DB >> 10618102

Species-specific PCR as a tool for the identification of Burkholderia gladioli.

P W Whitby1, L C Pope, K B Carter, J J LiPuma, T L Stull.   

Abstract

Burkholderia gladioli colonizes the respiratory tracts of patients with cystic fibrosis and chronic granulomatous disease. However, due to the high degree of phenotypic similarity between this species and closely related species in the Burkholderia cepacia complex, accurate identification is difficult. Incorrect identification of these species may have serious repercussions for the management of patients with cystic fibrosis. To develop an accurate procedure for the identification of B. gladioli, a molecular method to discriminate between this species and other species commonly isolated from the sputa of patients with cystic fibrosis was investigated. The 23S ribosomal DNA was cloned from several clinical isolates of B. gladioli, and the nucleotide sequence was determined. Computer-assisted sequence comparisons indicated four regions of the 23S rRNA specific for this species; these regions were used to design three primer pairs for species-specific PCR. Two of the primer pairs showed 100% sensitivity and specificity for B. gladioli when tested against a panel of 47 isolates comprising 19 B. gladioli isolates and 28 isolates of 16 other bacterial species. One of the primer pairs was further assessed for species specificity by using a panel of 102 isolates obtained from the Burkholderia cepacia Research Laboratory and Repository. The species-specific PCR was positive for 70 of 74 isolates of B. gladioli and was negative for all other bacterial species examined. Overall, this primer pair displayed a sensitivity and specificity of 96% (89 of 93) and 100%, respectively. These data demonstrate the potential of species-specific PCR for the identification of B. gladioli.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618102      PMCID: PMC88710          DOI: 10.1128/JCM.38.1.282-285.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  A BACTERIAL DISEASE OF GLADIOLUS.

Authors:  L McCulloch
Journal:  Science       Date:  1921-08-05       Impact factor: 47.728

Review 2.  Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplantation.

Authors:  S U Khan; S M Gordon; P C Stillwell; T J Kirby; A C Arroliga
Journal:  Pediatr Infect Dis J       Date:  1996-07       Impact factor: 2.129

3.  Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis.

Authors:  J C Christenson; D F Welch; G Mukwaya; M J Muszynski; R E Weaver; D J Brenner
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

4.  Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis.

Authors:  M L Wilsher; J Kolbe; A J Morris; D F Welch
Journal:  Am J Respir Crit Care Med       Date:  1997-04       Impact factor: 21.405

5.  Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli.

Authors:  I A Baxter; P A Lambert; I N Simpson
Journal:  J Antimicrob Chemother       Date:  1997-02       Impact factor: 5.790

6.  Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.

Authors:  J J LiPuma; B J Dulaney; J D McMenamin; P W Whitby; T L Stull; T Coenye; P Vandamme
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

Authors:  P Vandamme; B Holmes; M Vancanneyt; T Coenye; B Hoste; R Coopman; H Revets; S Lauwers; M Gillis; K Kersters; J R Govan
Journal:  Int J Syst Bacteriol       Date:  1997-10

8.  Detection of Pseudomonas (Burkholderia) cepacia using PCR.

Authors:  P W Campbell; J A Phillips; G J Heidecker; M R Krishnamani; R Zahorchak; T L Stull
Journal:  Pediatr Pulmonol       Date:  1995-07

9.  Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis.

Authors:  P W Whitby; H L Dick; P W Campbell; D E Tullis; A Matlow; T L Stull
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Severe Burkholderia (Pseudomonas) gladioli infection in chronic granulomatous disease: report of two successfully treated cases.

Authors:  J P Ross; S M Holland; V J Gill; E S DeCarlo; J I Gallin
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

View more
  17 in total

1.  Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors:  D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Identification of members of the Burkholderia cepacia complex by species-specific PCR.

Authors:  P W Whitby; K B Carter; K L Hatter; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

Review 3.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.

Authors:  Agnes Ferroni; Isabelle Sermet-Gaudelus; Eric Abachin; Gilles Quesne; Gerard Lenoir; Patrick Berche; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

5.  Vertical transmission of endobacteria in the arbuscular mycorrhizal fungus Gigaspora margarita through generation of vegetative spores.

Authors:  V Bianciotto; A Genre; P Jargeat; E Lumini; G Bécard; P Bonfante
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

Review 6.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

7.  Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR.

Authors:  P W Whitby; K B Carter; J L Burns; J A Royall; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

8.  Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis.

Authors:  Tom Coenye; Theodore Spilker; Rebecca Reik; Peter Vandamme; John J Lipuma
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

9.  Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays.

Authors:  T Coenye; L Liu; P Vandamme; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

10.  Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction.

Authors:  Tom Coenye; Peter Vandamme; John J LiPuma
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.